Jong-Ho Hong
Chief Executive Officer at KUKJEON PHARMACEUTICAL CO., LTD
Net worth: 84 M $ as of 31/05/2024
Profile
Jong-Ho Hong is currently the Chief Executive Officer at Kukjeon Pharm Co., Ltd.
and the Chief Executive Officer & Director at Kukjeon Pharmaceutical Co., Ltd.
He has a graduate degree from Sogang University and an undergraduate degree from Sungkyunkwan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/06/2024 | 21,373,361 ( 43.56% ) | 84 M $ | 31/05/2024 |
Jong-Ho Hong active positions
| Companies | Position | Start |
|---|---|---|
| KUKJEON PHARMACEUTICAL CO., LTD | Chief Executive Officer | - |
Kukjeon Pharm Co., Ltd.
 Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Chief Executive Officer | - |
Training of Jong-Ho Hong
| Sogang University | Graduate Degree |
| Sungkyunkwan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KUKJEON PHARMACEUTICAL CO., LTD | Process Industries |
| Private companies | 1 |
|---|---|
Kukjeon Pharm Co., Ltd.
Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Jong-Ho Hong
